Alyeska Investment Group, L.P. 13D and 13G filings for Unity Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | Unity Biotechnology, Inc. UBX | Alyeska Investment Group, L.P. | 1,578,091 9.170% | -89,823 (-5.39%) | Filing |
| 2024-11-14 4:35 pm Sale | 2024-09-30 | 13G | Unity Biotechnology, Inc. UBX | Alyeska Investment Group, L.P. | 1,667,914 9.990% | -8,904 (-0.53%) | Filing |
| 2024-02-14 1:52 pm Purchase | 2023-12-31 | 13G | Unity Biotechnology, Inc. UBX | Alyeska Investment Group, L.P. | 1,676,818 9.990% | 257,818 (+18.17%) | Filing |
| 2023-02-14 2:07 pm Purchase | 2022-12-31 | 13G | Unity Biotechnology, Inc. UBX | Alyeska Investment Group, L.P. | 1,419,000 9.990% | 1,419,000 (New Position) | Filing |